Literature DB >> 32128574

Topoisomerase 2β mutation impairs early B-cell development.

Olivier Papapietro1,2, Anita Chandra1,3, Davide Eletto1, Sarah Inglott4, Vincent Plagnol5, James Curtis1, Mailis Maes1, Ali Alisaac1,6, Adriana S Albuquerque7, Eugenie Basseres2, Olivier Hermine8,9, Capucine Picard9,10,11, Alain Fischer8,9,11,12, Anne Durandy8,13, Sven Kracker8,13, Siobhan O Burns7,14, Delphine Cuchet-Lourenco1, Klaus Okkenhaug3, Sergey Nejentsev1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32128574      PMCID： PMC7612232          DOI： 10.1182/blood.2019003299

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  25 in total

1.  B cell immunodeficiency, distal limb abnormalities, and urogenital malformations in a three generation family: a novel autosomal dominant syndrome?

Authors:  P Edery; F Le Deist; M L Briard; M Debré; A Munnich; C Griscelli; A Fischer; S Lyonnet
Journal:  J Med Genet       Date:  2001-07       Impact factor: 6.318

2.  Structural basis for gate-DNA recognition and bending by type IIA topoisomerases.

Authors:  Ken C Dong; James M Berger
Journal:  Nature       Date:  2007-12-20       Impact factor: 49.962

Review 3.  Primary antibody deficiencies.

Authors:  Anne Durandy; Sven Kracker; Alain Fischer
Journal:  Nat Rev Immunol       Date:  2013-06-14       Impact factor: 53.106

4.  Genome Organization Drives Chromosome Fragility.

Authors:  Andres Canela; Yaakov Maman; Seolkyoung Jung; Nancy Wong; Elsa Callen; Amanda Day; Kyong-Rim Kieffer-Kwon; Aleksandra Pekowska; Hongliang Zhang; Suhas S P Rao; Su-Chen Huang; Peter J Mckinnon; Peter D Aplan; Yves Pommier; Erez Lieberman Aiden; Rafael Casellas; André Nussenzweig
Journal:  Cell       Date:  2017-07-20       Impact factor: 41.582

5.  Active heterodimers are formed from human DNA topoisomerase II alpha and II beta isoforms.

Authors:  H Biersack; S Jensen; I Gromova; I S Nielsen; O Westergaard; A H Andersen
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-06       Impact factor: 11.205

6.  Glucocorticoid Receptor Transcriptional Activation via the BRG1-Dependent Recruitment of TOP2β and Ku70/86.

Authors:  Kevin W Trotter; Heather A King; Trevor K Archer
Journal:  Mol Cell Biol       Date:  2015-06-08       Impact factor: 4.272

7.  Clofarabine, cyclophosphamide and etoposide as single-course re-induction therapy for children with refractory/multiple relapsed acute lymphoblastic leukaemia.

Authors:  Franco Locatelli; Anna M Testi; Maria Ester Bernardo; Carmelo Rizzari; Alice Bertaina; Pietro Merli; Andrea Pession; Eugenia Giraldi; Rosanna Parasole; Walter Barberi; Marco Zecca
Journal:  Br J Haematol       Date:  2009-08-29       Impact factor: 6.998

8.  A multi-center phase I study of clofarabine, etoposide and cyclophosphamide in combination in pediatric patients with refractory or relapsed acute leukemia.

Authors:  N Hijiya; P Gaynon; E Barry; L Silverman; B Thomson; R Chu; T Cooper; R Kadota; M Rytting; P Steinherz; V Shen; S Jeha; R Abichandani; W L Carroll
Journal:  Leukemia       Date:  2009-09-10       Impact factor: 11.528

Review 9.  Roles of eukaryotic topoisomerases in transcription, replication and genomic stability.

Authors:  Yves Pommier; Yilun Sun; Shar-Yin N Huang; John L Nitiss
Journal:  Nat Rev Mol Cell Biol       Date:  2016-09-21       Impact factor: 113.915

10.  Topoisomerase II beta interacts with cohesin and CTCF at topological domain borders.

Authors:  Liis Uusküla-Reimand; Huayun Hou; Payman Samavarchi-Tehrani; Matteo Vietri Rudan; Minggao Liang; Alejandra Medina-Rivera; Hisham Mohammed; Dominic Schmidt; Petra Schwalie; Edwin J Young; Jüri Reimand; Suzana Hadjur; Anne-Claude Gingras; Michael D Wilson
Journal:  Genome Biol       Date:  2016-08-31       Impact factor: 13.583
View more
  3 in total

1.  Evolutionary History of TOPIIA Topoisomerases in Animals.

Authors:  Filipa Moreira; Miguel Arenas; Arnaldo Videira; Filipe Pereira
Journal:  J Mol Evol       Date:  2022-02-14       Impact factor: 2.395

2.  Topoisomerase 2β and DNA topology during B cell development.

Authors:  Olivier Papapietro; Sergey Nejentsev
Journal:  Front Immunol       Date:  2022-08-15       Impact factor: 8.786

Review 3.  Beyond monogenetic rare variants: tackling the low rate of genetic diagnoses in predominantly antibody deficiency.

Authors:  Emily S J Edwards; Julian J Bosco; Samar Ojaimi; Robyn E O'Hehir; Menno C van Zelm
Journal:  Cell Mol Immunol       Date:  2020-08-17       Impact factor: 11.530
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.